These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7832812)

  • 1. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
    Jun CD; Yoon HJ; Kim HM; Chung HT
    Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL; Perera PY; Salkowski CA; Vogel SN
    J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages.
    Jun CD; Choi BM; Kim HM; Chung HT
    J Immunol; 1995 Jun; 154(12):6541-7. PubMed ID: 7759887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
    Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
    J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
    Hori K; Ehrke MJ; Mace K; Mihich E
    Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
    Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
    J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM; Vogel SN
    J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.
    Gazzinelli RT; Oswald IP; Hieny S; James SL; Sher A
    Eur J Immunol; 1992 Oct; 22(10):2501-6. PubMed ID: 1396957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP analogue as a triggering signal for the induction of nitric oxide synthesis in murine peritoneal macrophages.
    Park YC; Park SJ; Jun CD; Kim GE; Park KI; Kim HD; Park RK; Chung HT
    Cell Immunol; 1997 Jul; 179(1):41-7. PubMed ID: 9259770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine interactions in experimental cutaneous leishmaniasis.
    Solbach W; Röllinghoff M; Stenger S; Bogdan C
    Behring Inst Mitt; 1991 Feb; (88):230-8. PubMed ID: 1904708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
    Akiyama Y; Yamasaki T; Fukuda M; Moritake K
    No To Shinkei; 1995 Apr; 47(4):349-55. PubMed ID: 7772402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
    Klostergaard J; Leroux ME; Hung MC
    J Immunol; 1991 Oct; 147(8):2802-8. PubMed ID: 1918993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages.
    Lakics V; Vogel SN
    J Immunol; 1998 Sep; 161(5):2490-500. PubMed ID: 9725248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.
    Polsinelli T; Meltzer MS; Fortier AH
    J Immunol; 1994 Aug; 153(3):1238-45. PubMed ID: 8027551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
    Ding AH; Nathan CF; Stuehr DJ
    J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
    Chang MJ; Modzelewski RA; Russell DM; Johnson CS
    Cancer Res; 1996 Feb; 56(4):886-91. PubMed ID: 8631029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.